Pursuing progress against childhood leukemia! 💛 #StandUpToCancer recently announced that @CaitlinZebley of @StJudeResearch is the recipient of the 2026 SU2C Maverick Early Career Scientist Award (presented earlier this year by SU2C Scientific Advisory Chair Dr. William G. Nelson). Funding from the award will support Dr. Zebley’s ongoing research to develop effective CAR T-cell therapies for children with acute myelogenous leukemia (AML). Congratulations, Dr. Zebley! Learn more at SU2C.link/MaverickAward. #ChildhoodCancer #Immunotherapy
- Pursuing progress against childhood leukemia! 💛 #StandUpToCancer recently announced that @CaitlinZebley of @StJudeResearch is the recipient of the 2026 SU2C Maverick Early Career Scientist Award (presented earlier this year by SU2C Scientific Advisory Chair Dr. William G. Nelson). Funding from the award will support Dr. Zebley’s ongoing research to develop effective CAR T-cell therapies for children with acute myelogenous leukemia (AML). Congratulations, Dr. Zebley! Learn more at SU2C.link/MaverickAward. #ChildhoodCancer #Immunotherapy